| 2DR Stock | | | EUR 174.80 3.20 1.86% |
CFO
Richard Buchholz is Chief Financial Officer of Inspire Medical Systems since 2014.
| Age | 55 |
| Tenure | 11 years |
| Phone | 844 672 4357 |
| Web | https://www.inspiresleep.com |
Inspire Medical Management Efficiency
The company has return on total asset
(ROA) of
(0.0692) % which means that it has lost $0.0692 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.1238) %, meaning that it generated substantial loss on money invested by shareholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Inspire Medical Systems has accumulated 15.8
M in total debt with debt to equity ratio
(D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Inspire Medical Systems has a current ratio of 13.16, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Inspire Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Inspire Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Inspire Medical Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Inspire to invest in growth at high rates of return. When we think about Inspire Medical's use of debt, we should always consider it together with cash and equity.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and Europe. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. INSPIRE MED operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 341 people. Inspire Medical Systems (2DR) is traded on Frankfurt Exchange in Germany and employs 755 people.
Management Performance
Inspire Medical Systems Leadership Team
Elected by the shareholders, the Inspire Medical's board of directors comprises two types of representatives: Inspire Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspire. The board's role is to monitor Inspire Medical's management team and ensure that shareholders' interests are well served. Inspire Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspire Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Georgia GarinoisMelenikiotou, Director | |
| Timothy Herbert, President, Chief Executive Officer, Director | |
| Philip Ebeling, Chief Operating Officer | |
| Steven Jandrich, Chief Compliance Officer, Vice President of Human Resources | |
| Andreas Henke, VP Europe | |
| Casey Tansey, Independent Director | |
| Richard Buchholz, Chief Financial Officer | |
| Mudit Jain, Independent Director | |
| Chau Khuong, Independent Director | |
| Martin Abrams, VP Experience | |
| Gary Ellis, Independent Director | |
| John Rondoni, Chief Officer | |
| Shawn McCormick, Independent Director | |
| Randall Ban, Chief Commercial Officer | |
| Dana Mead, Independent Director | |
| Shelley Broader, Director | |
| Ivan Lubogo, Sr Sales | |
| Marilyn Nelson, Independent Chairman of the Board | |
| Jerry Griffin, Independent Director | |
| Bryan Phillips, Senior Vice President Chief Compliance Officer, General Counsel, Company Secretary | |
Inspire Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspire Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Inspire Stock
When determining whether Inspire Medical Systems is a good investment, qualitative aspects like company
management, corporate governance, and ethical practices play a significant role. A
comparison with peer companies also provides context and helps to understand if Inspire Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Inspire Medical Systems Stock.
Highlighted below are key reports to facilitate an investment decision about Inspire Medical Systems Stock: Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
You can also try the
Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspire Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.